Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2025 Filed Mar 7, 2025 22:35 UTC |
Tornos IvanDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 10,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004971 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,268 Underlying: Common Stock · 10,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 10,268 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F3 · derivative.expiration_date: 10,268 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:35 UTC |
Tornos IvanDirector · President & CEO
|
Tax withholdingCommon Stock | 5,679 | $104.86 | $595,499.94 |
DisclosureSEC source: 0001062993-25-004971 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,753 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:35 UTC |
Tornos IvanDirector · President & CEO
|
Exercise / conversionCommon Stock | 10,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004971 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:34 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004969 · form4.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,559 Underlying: Common Stock · 4,560 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 4,560 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F3 · derivative.expiration_date: 4,560 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:34 UTC |
Upadhyay SuketuExec. VP, CFO
|
Tax withholdingCommon Stock | 2,029 | $104.86 | $212,760.94 |
DisclosureSEC source: 0001062993-25-004969 · form4.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,853 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:34 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionCommon Stock | 4,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004969 · form4.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:32 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004968 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,364 Underlying: Common Stock · 2,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: 2,365 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F2 · derivative.expiration_date: 2,365 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:32 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004968 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:37 UTC |
Winkler LoriSVP and CHRO
|
SaleCommon Stock | 1,443 | $104.40 | $150,649.20 |
DisclosureSEC source: 0001062993-25-004974 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,768 Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:36 UTC |
Stellato Paul AVP, Controller & CAO
|
GrantRestricted Stock Units · Derivative | 2,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003855 · form4.xml · derivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,458 Underlying: Common Stock · 2,458 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:36 UTC |
Winkler LoriSVP and CHRO
|
GrantRestricted Stock Units · Derivative | 7,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003854 · form4.xml · derivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,040 Underlying: Common Stock · 7,040 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:35 UTC |
Bezjak MarkPresident, Americas
|
GrantRestricted Stock Units · Derivative | 8,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003853 · form4.xml · derivative · entry 1 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,829 Underlying: Common Stock · 8,829 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:33 UTC |
Yi SangGroup President, Asia Pacific
|
GrantRestricted Stock Units · Derivative | 8,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003852 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,352 Underlying: Common Stock · 8,352 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:33 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
GrantRestricted Stock Units · Derivative | 9,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003851 · form4.xml · derivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,545 Underlying: Common Stock · 9,545 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:30 UTC |
Tornos IvanDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 57,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003849 · form4.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,269 Underlying: Common Stock · 57,269 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:31 UTC |
Upadhyay SuketuExec. VP, CFO
|
GrantRestricted Stock Units · Derivative | 19,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003850 · form4.xml · derivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,090 Underlying: Common Stock · 19,090 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:30 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
GrantRestricted Stock Units · Derivative | 7,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003848 · form4.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,875 Underlying: Common Stock · 7,875 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:15 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionRestricted Stock Units · Derivative | 2,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003349 · form4.xml · derivative · entry 3 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,037 Underlying: Common Stock · 2,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:15 UTC |
Bezjak MarkPresident, Americas
|
Tax withholdingCommon Stock | 694 | $103.46 | $71,801.24 |
DisclosureSEC source: 0001062993-25-003349 · form4.xml · nonDerivative · entry 2 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,151 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:15 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionCommon Stock | 2,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003349 · form4.xml · nonDerivative · entry 1 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:14 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003348 · form4.xml · derivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,811 Underlying: Common Stock · 1,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:14 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 465 | $103.46 | $48,108.90 |
DisclosureSEC source: 0001062993-25-003348 · form4.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,211 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:14 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 1,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003348 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:12 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003345 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,492 Underlying: Common Stock · 2,247 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:12 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Tax withholdingCommon Stock | 885 | $103.46 | $91,562.10 |
DisclosureSEC source: 0001062993-25-003345 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,768 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:12 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003345 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:11 UTC |
Ellingson RachelChief Administrative Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003344 · form4.xml · derivative · entry 3 Ellingson Rachel · CIK 0001557271 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,131 Underlying: Common Stock · 1,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:11 UTC |
Ellingson RachelChief Administrative Officer
|
Tax withholdingCommon Stock | 491 | $103.46 | $50,798.86 |
DisclosureSEC source: 0001062993-25-003344 · form4.xml · nonDerivative · entry 2 Ellingson Rachel · CIK 0001557271 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,906 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:11 UTC |
Ellingson RachelChief Administrative Officer
|
Exercise / conversionCommon Stock | 1,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003344 · form4.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:10 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 702 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003340 · form4.xml · derivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,402 Underlying: Common Stock · 702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F4 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:10 UTC |
Stellato Paul AVP, Controller & CAO
|
Tax withholdingCommon Stock | 258 | $103.46 | $26,692.68 |
DisclosureSEC source: 0001062993-25-003340 · form4.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,926 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:10 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionCommon Stock | 702 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003340 · form4.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 100 shares acquired under the Employee Stock Purchase Plan through February 18, 2025. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:09 UTC |
Tornos IvanDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003339 · form4.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,991 Underlying: Common Stock · 15,996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:09 UTC |
Tornos IvanDirector · President and CEO
|
Tax withholdingCommon Stock | 8,846 | $103.46 | $915,207.16 |
DisclosureSEC source: 0001062993-25-003339 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,164 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:09 UTC |
Tornos IvanDirector · President and CEO
|
Exercise / conversionCommon Stock | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003339 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:08 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 5,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003336 · form4.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,890 Underlying: Common Stock · 5,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:08 UTC |
Upadhyay SuketuExec. VP, CFO
|
Tax withholdingCommon Stock | 2,423 | $103.46 | $250,683.58 |
DisclosureSEC source: 0001062993-25-003336 · form4.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,322 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:08 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionCommon Stock | 5,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003336 · form4.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:07 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 2,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003335 · form4.xml · derivative · entry 3 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,901 Underlying: Common Stock · 2,451 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F3 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:07 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 645 | $103.46 | $66,731.70 |
DisclosureSEC source: 0001062993-25-003335 · form4.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,941 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:07 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 2,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003335 · form4.xml · nonDerivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:05 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003332 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,764 Underlying: Common Stock · 2,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F2 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:05 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003332 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:03 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 11,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002917 · form4.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,138 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:03 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 11,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002917 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 216 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:02 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002916 · form4.xml · derivative · entry 4 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,208 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:02 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 1,802 | $101.00 | $182,002.00 |
DisclosureSEC source: 0001062993-25-002916 · form4.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,769 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:02 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 7,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002916 · form4.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 27 shares acquired pursuant to dividend reinvestment through February 18, 2025. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:01 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 9,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002915 · form4.xml · derivative · entry 4 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,174 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:01 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 2,414 | $101.00 | $243,814.00 |
DisclosureSEC source: 0001062993-25-002915 · form4.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,135 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.